Copyright
©The Author(s) 2020.
World J Clin Cases. Oct 6, 2020; 8(19): 4380-4387
Published online Oct 6, 2020. doi: 10.12998/wjcc.v8.i19.4380
Published online Oct 6, 2020. doi: 10.12998/wjcc.v8.i19.4380
Table 2 Univariate logistic regression and multivariate Cox proportional-hazards regression for recurrence-free survival of patients with hepatocellular carcinoma who received hepatic resection or percutaneous radiofrequency ablation
Variables | Univariate logistic regression | Cox proportional-hazards regression | |
P value | Hazard ratio (95%CI) | P value | |
Albumin (g/dL) | 0.018 | 0.325 (0.109–0.875) | 0.020 |
AFP: normal vs abnormal | 0.037 | 1.658 (1.135–3.258) | 0.023 |
Number of tumours | |||
1 | 1.000 | 0.023 | |
2 | 5.784 (1.387–20.268) | 0.015 | |
3 | 7.458 (0.896–87.257) | 0.056 | |
TNM stage | < 0.001 | ||
I | |||
II | |||
Days of hospital stay during initial therapy | 0.028 | 1.058 (1.005–1.224) | 0.027 |
HR vs PRFA | 0.043 | 1.045 (0.325–2.838) | 0.039 |
- Citation: Zhang YH, Su B, Sun P, Li RM, Peng XC, Cai J. Percutaneous radiofrequency ablation is superior to hepatic resection in patients with small hepatocellular carcinoma. World J Clin Cases 2020; 8(19): 4380-4387
- URL: https://www.wjgnet.com/2307-8960/full/v8/i19/4380.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i19.4380